Subscribe to our free daily newsletters
. Earth Science News .




Subscribe to our free daily newsletters



Researchers despondent as AIDS vaccine still out of reach

by Staff Writers
Washington (AFP) May 18, 2008
A quarter of a century since the virus that causes AIDS was identified, a vaccine against the deadly disease remains frustratingly out of reach despite a well-funded global effort to find a cure.

"Nearly a billion dollars is spent globally on HIV/AIDS research annually, and yet the sobering reality is that at present there are no promising candidates for an HIV vaccine," Bruce Walker of Harvard Medical School wrote in the May 9 edition of the journal Science.

The research community was dealt a heavy blow in September when the clinical trials of the most promising and widely tested HIV vaccine candidate were halted after it turned out to be a failure.

Early results showed that, rather than preventing HIV or reducing the viral load in people who received it, the experimental vaccine may have increased their chances of become infected.

"We share in the disappointment of the research and HIV communities today. Sadly, developing an effective AIDS vaccine remains one of the most challenging tasks facing modern medicine," Peter Kim, president of Merck Research Laboratories, which developed the candidate, said at the time.

Merck's vaccine aimed to stimulate T cells, a type of white blood cell key to the body's immune response, taking a different approach than numerous more traditional vaccines already tested without success.

"The (research) community is depressed because we see no hopeful route to success," American biologist and Nobel prize laureate David Baltimore said of the quest for an AIDS vaccine, at the opening of the latest conference of the American Association for the Advancement of Science, in February.

"Knowing how critical it is to get a vaccine for HIV, developers are moving ahead, even recognizing the long odds for success," he added.

The unique qualities of the HIV pathogen make developing a vaccine particularly challenging, Walker explained.

It has an enormous diversity of genetic sequences, and a great capacity to mutate and adapt, he said.

HIV strains can be divided into three different groups, of which the first, M, is itself divided into nine subtypes, with an undetermined number of variants.

One of the sub-type viruses can vary from 20 to 38 percent in Africa, where multiple variants exist.

Moreover, the retrovirus can undergo more mutations during the infection of a single individual than the entire world flu epidemic, which requires development of a new vaccine every year, Walker said.

With 33 million people living with HIV worldwide, developing a vaccine to protect simultaneously against all the pathogen's variants is a considerable challenge, Walker said.

And the fact that HIV is an infection of the immune system makes the task even more complicated, since traditional vaccines work by boosting the immune system to fight pathogens.

"There are so many things we do not know in this field of HIV vaccines," Anthony Fauci, director of the National Institute of Allergy and Infectious Diseases, said at a summit his organization hosted in March to evaluate the situation going forward following the failure of the Merck vaccine.

At the summit, leading AIDS specialists discussed avenues of research that remain largely unexplored, such as protection at the level of the mucous membranes, and the natural immunity of certain species of monkey to the primate equivalent of HIV, Simian immunodeficiency virus (SIV).

Community
Email This Article
Comment On This Article

Share This Article With Planet Earth
del.icio.usdel.icio.us DiggDigg RedditReddit
YahooMyWebYahooMyWeb GoogleGoogle FacebookFacebook



Related Links
Epidemics on Earth - Bird Flu, HIV/AIDS, Ebola



Memory Foam Mattress Review
Newsletters :: SpaceDaily :: SpaceWar :: TerraDaily :: Energy Daily
XML Feeds :: Space News :: Earth News :: War News :: Solar Energy News


From 'gay plague' to global tragedy: An AIDS anniversary
Paris (AFP) May 18, 2008
The campaign against AIDS marks an important anniversary this week, bringing to mind victories of science and the human spirit but also defeats, stigma and ignorance in a combat that has claimed more lives than World War I.







  • US military planes deliver aid to quake-hit China
  • China's vice premier arrives in quake-hit Sichuan: report
  • China quake survivors shiver in rain-soaked camp: state media
  • Nationalism imbues China quake volunteer drive

  • Earth Impacts Linked To Human-Caused Climate Change
  • Studies Unveil Greenhouse Processes Back 800000 Years
  • NCAR Installs Supercomputer For Critical Research On Climate Change And Severe Weather
  • McCain splits with Bush on climate change

  • Taiwan shares satellite images with China of quake disaster area
  • Raytheon Reaches Key Milestone On NASA Glory Space Program
  • USGS Awards Satellite Imagery Contracts: Enhancing Access To Users
  • Bluesky Launches 3D Computer Models Of Britain's Cities

  • Analysis: Fall River fights LNG facility
  • Trade minister urges EU to want Canada's oil
  • Biofuels must not deprive poor of food: EU official
  • MIT Creates New Material For Fuel Cells

  • Researchers despondent as AIDS vaccine still out of reach
  • Doctor's mission: prevent disease after China quake
  • From 'gay plague' to global tragedy: An AIDS anniversary
  • Beijing confirms first virus deaths: report

  • Wildlife numbers plummet globally: WWF
  • Warming Climate Is Changing Life On A Global Scale
  • US lists polar bears as threatened
  • Researchers Discover Architecture For Fundamental Processes Of Life

  • NOAA Reports Coastal Waters Show Decline In Contaminants
  • Cleaning Up The Oceans With Wakame Waste
  • Chinese leader seeks Japanese help on environment
  • Toxic ponds kill ducks in Canada

  • Justice In The Brain: Equity And Efficiency Are Encoded Differently
  • Nearly One-Third Of US Parents Don't Know What To Expect Of Infants
  • Walker's World: Bye-bye boomers
  • United We Stand: When Cooperation Butts Heads With Competition

  • The content herein, unless otherwise known to be public domain, are Copyright 1995-2007 - SpaceDaily.AFP and UPI Wire Stories are copyright Agence France-Presse and United Press International. ESA Portal Reports are copyright European Space Agency. All NASA sourced material is public domain. Additional copyrights may apply in whole or part to other bona fide parties. Advertising does not imply endorsement,agreement or approval of any opinions, statements or information provided by SpaceDaily on any Web page published or hosted by SpaceDaily. Privacy Statement